Empowered Funds’s Vir Biotechnology VIR Stock Holding History

Empowered Funds’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$180K	Sell	17,661 -12,176	-41%	-$116K	﹤0.01%	2043
2026 Q1	$267K	Sell	29,837 -1,029	-3%	-$8.2K	﹤0.01%	1876
2025 Q4	$186K	Buy	30,866 +841	+3%	+$5.01K	﹤0.01%	944
2025 Q3	$171K	Sell	30,025 -232	-0.8%	-$1.19K	﹤0.01%	1745
2025 Q2	$152K	Sell	30,257 -1,499	-5%	-$8.04K	﹤0.01%	1677
2025 Q1	$206K	Sell	31,756 -258,870	-89%	-$2.3M	﹤0.01%	1503
2024 Q4	$2.13M	Sell	290,626 -39,155	-12%	-$309K	0.03%	710
2024 Q3	$2.47M	Sell	329,781 -163,723	-33%	-$1.42M	0.04%	590
2024 Q2	$4.39M	Buy	493,504 +35,460	+8%	+$340K	0.08%	363
2024 Q1	$4.64M	Buy	458,044 +34,640	+8%	+$353K	0.08%	333
2023 Q4	$4.26M	Buy	423,404 +38,269	+10%	+$350K	0.11%	278
2023 Q3	$3.61M	Buy	+385,135	New	+$5.49M	0.11%	257

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Empowered Funds's VIR Position: Q2 2026 in Review

Empowered Funds reduced its Vir Biotechnology (VIR) stake by 41% in Q2 2026, selling an estimated $116K and leaving 17,661 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

Empowered Funds first reported a position in VIR in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.64M in Q1 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Empowered Funds held 17,661 shares of Vir Biotechnology worth $180K as of Q2 2026.
Empowered Funds sold 12,176 Vir Biotechnology shares in Q2 2026, an estimated $116K.
Vir Biotechnology made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #2043 holding.
Empowered Funds first reported a position in Vir Biotechnology in Q3 2023 and has held it in 12 quarters since.
Empowered Funds's Vir Biotechnology position peaked at $4.64M in Q1 2024.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.